Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new type of personalised cancer treatment that “trains” a patient’s immune system to attack their cancer. However, use is largely restricted at the moment due in large part to life threatening side effects.
WEHI is where the world’s brightest minds collaborate and innovate to make discoveries that will help people in Australia and around the world live healthier, longer lives.
View Beneficiary Profile